The study’s authors examined data from more than 15,000 patients who had their first intracerebral hemorrhage from January 2003 to December 2021

Researchers uncovered new details about how mitral regurgitation can impact one-year TAVR outcomes, sharing their findings in the Journal of the American Heart Association.

Researchers explored data from more than 400 STEMI patients, presenting their work at ESC Congress 2023 and publishing it in the New England Journal of Medicine.

Medicare enrollees paid a total of $3.4 billion in out-of-pocket costs for these drugs in 2022 alone, according to new data shared by the White House. 

New research published in the Canadian Journal of Cardiology represents one the most detailed pictures to date of the long-term impact of ViV TMVR.

Boston Scientific, which funded the study, hopes these results can help the company gain FDA approval for its PFA device in the months ahead. 

The Body Scan Connected Health Station includes a high-strength glass platform with four weight sensors and 14 ITO electrodes and a retractable handle with four stainless steel electrodes.

The ILUMIEN IV and OCTOBER trials helped illustrate that the benefits of intravascular ultrasound also are seen with optical coherence tomography. Both trials were included in the new meta-analysis presented at ESC Congress 2023.

Once physicians confirm a patient's CAD risk is low, they can feel comfortable putting diagnostic testing on hold. 

If successful, the group's first-in-class medication would be able to target inflammation in CVD patients before it even occurs.